Evidence map›Paper›PMID 30377252›Full record

ArticleThe Journal of biological chemistry2019

Unicellular ancestry and mechanisms of diversification of Goodpasture antigen-binding protein.

Carl Darris, Fernando Revert, Francisco Revert-Ros, Roberto Gozalbo-Rovira, Andrew Feigley, Aaron Fidler, Ernesto Lopez-Pascual, Juan Saus, Billy G Hudson

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04626089 (Adaptive Study for Efficacy and Safety of Metformin Glycinate for the Treatment of Patients With MS and DM2, Hospitalized With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb.), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04626089 phase2withdrawnstarted 2021, after this paper: background citation

Adaptive Study for Efficacy and Safety of Metformin Glycinate for the Treatment of Patients With MS and DM2, Hospitalized With Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. Randomized, Double-Blind, Phase IIIb.

Ran2021Enrolled0Registered outcomes12Posted comparisons0ConditionsMetabolic Syndrome, Severe Acute Respiratory Syndrome Coronavirus 2, Type 2 DiabetesArmsMetformin glycinate, Placebo Oral Tablet
Open the trial in the graph
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Carl DarrisFrom the Department of Medicine/Division of Nephrology and Hypertension and Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee 37232, carl.darris@vanderbilt.edu.ORCID 0000-0002-1320-7612
Fernando RevertFibrostatin, SL, Scientific Park of the University of Valencia, 46980 Paterna, Valencia, Spain.
Francisco Revert-RosFibrostatin, SL, Scientific Park of the University of Valencia, 46980 Paterna, Valencia, Spain.
Roberto Gozalbo-RoviraFibrostatin, SL, Scientific Park of the University of Valencia, 46980 Paterna, Valencia, Spain.
Andrew FeigleyFrom the Department of Medicine/Division of Nephrology and Hypertension and Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee 37232.
Aaron FidlerFrom the Department of Medicine/Division of Nephrology and Hypertension and Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee 37232.
Ernesto Lopez-PascualFibrostatin, SL, Scientific Park of the University of Valencia, 46980 Paterna, Valencia, Spain.
Juan SausFibrostatin, SL, Scientific Park of the University of Valencia, 46980 Paterna, Valencia, Spain.
Billy G HudsonFrom the Department of Medicine/Division of Nephrology and Hypertension and Vanderbilt University Medical Center, Vanderbilt University, Nashville, Tennessee 37232, billy.hudson@vanderbilt.edu.
Parc Científic de la Universitat de València · ESAspirus · USBreast Cancer Research Foundation · USUniversitat de València · ESVanderbilt University · US

Funding

STUDIES ON THE STRUCTURE OF BASEMENT MEMBRANESR01DK018381 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Sergey Petrovich Budko, BILLY GERALD HUDSON · 1986 to 2026
$12.4M
Undergraduate Research Internships in Pathobiology of Diabetic NephropathyR25DK096999 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BILLY GERALD HUDSON · 2012 to 2026
$1.6M
NIDDK NIH HHS R01 DK018381NIDDK NIH HHS R25 DK096999
6 · The paper itself

Abstract

The emergence of the basement membrane (BM), a specialized form of extracellular matrix, was essential in the unicellular transition to multicellularity. However, the mechanism is unknown. Goodpasture antigen-binding protein (GPBP), a BM protein, was uniquely poised to play diverse roles in this transition owing to its multiple isoforms (GPBP-1, -2, and -3) with varied intracellular and extracellular functions (ceramide trafficker and protein kinase). We sought to determine the evolutionary origin of GPBP isoforms. Our findings reveal the presence of GPBP in unicellular protists, with GPBP-2 as the most ancient isoform. In vertebrates, GPBP-1 assumed extracellular function that is further enhanced by membrane-bound GPBP-3 in mammalians, whereas GPBP-2 retained intracellular function. Moreover, GPBP-2 possesses a dual intracellular/extracellular function in cnidarians, an early nonbilaterian group. We conclude that GPBP functioning both inside and outside the cell was of fundamental importance for the evolutionary transition to animal multicellularity and tissue evolution.

Indexed as

Evolution, MolecularBasement MembraneHumansIsoenzymesProtein Serine-Threonine KinasesCERT1 protein, humanIsoenzymesProtein Serine-Threonine Kinasesbasement membraneevolutionextracellular matrixextracellular matrix proteingenomics

Identifiers

PMID30377252
PMCPMC6341388
OpenAlexW2899150426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.